About Redcliffe Labs
Redcliffe Labs is a company based in Noida (India) founded in 2018 by Aditya Kandoi, Ashish Dubey, and Dheeraj Jain. Redcliffe Labs has raised $116.42 million across 4 funding rounds from investors including LetsVenture, LeapFrog Investments and Schroders. The company has 2,308 employees as of August 11, 2024. Redcliffe Labs has completed 2 acquisitions, including Celara Diagnostics and Medicentre. Redcliffe Labs offers products and services including Diagnostic Tests, Health Packages, and Sample Collection. Redcliffe Labs operates in a competitive market with competitors including Dr Lal PathLabs, Sterling Accuris Diagnostics, Orange health, Metropolis India and Agilus Diagnostics, among others.
- Headquarter Noida, India
- Employees 2308 as on 11 Aug, 2024
- Founders Aditya Kandoi, Ashish Dubey, Dheeraj Jain
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Redcliffe Lifetech Private Limited
- Date of Incorporation 30 Jan, 2021
- Jurisdiction Noida, Uttar Pradesh, India
-
Annual Revenue
$41.86 M (USD)0as on Mar 31, 2023
-
Net Profit
-$41.56 M (USD)0as on Mar 31, 2023
-
EBITDA
-$38.4 M (USD)0as on Mar 31, 2023
-
Total Equity Funding
$116.42 M (USD)
in 4 rounds
-
Latest Funding Round
$42 M (USD), Series C
Sep 17, 2024
-
Investors
LetsVenture
& 12 more
-
Employee Count
2308
as on Aug 11, 2024
-
Investments & Acquisitions
Celara Diagnostics
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Redcliffe Labs
Redcliffe Labs offers a comprehensive portfolio of products and services, including Diagnostic Tests, Health Packages, and Sample Collection.
Services for booking and conducting medical diagnostic tests
Curated packages for comprehensive health checkups and reports
On-site services for collecting medical samples from users
Funding Insights of Redcliffe Labs
Redcliffe Labs has successfully raised a total of $116.42M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $42 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Redcliffe Labs
Redcliffe Labs has secured backing from 13 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include LetsVenture, LeapFrog Investments and Schroders.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm
|
Locked | Locked | Locked | |
|
Private equity fund focused on banking, finance, healthcare, and multiple sectors
|
Locked | Locked | Locked | |
|
Healthcare investment fund focused on innovation and social impact in India.
|
Locked | Locked | Locked |
Investor details for Redcliffe Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Redcliffe Labs
Redcliffe Labs has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Celara Diagnostics and Medicentre.
Investment portfolio details for Redcliffe Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of advanced diagnostic services, including imaging, laboratory tests, and other medical procedures, primarily catering to patients
|
Locked | Locked | 2017 | Locked | |
|
Chain of diagnostic centers
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for Redcliffe Labs
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Redcliffe Labs
Detailed financials for Redcliffe Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Redcliffe Labs Comparisons
Peer comparison for Redcliffe Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Redcliffe Labs
Redcliffe Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dr Lal PathLabs, Sterling Accuris Diagnostics, Orange health, Metropolis India and Agilus Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chain of pathology and radiology labs
|
|
| Locked | Locked | Locked |
Pathology diagnostic services are offered via a chain of labs.
|
|
| Locked | Locked | Locked |
At-home diagnostic tests are booked and collected by phlebotomists.
|
|
| Locked | Locked | Locked |
Diagnostic centers are operated as a nationwide chain.
|
|
| Locked | Locked | Locked |
Leading diagnostic chain providing quality blood test and full body checkup services
|
Detailed competitors of Redcliffe Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Redcliffe Labs
Complete news archive for Redcliffe Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Redcliffe Labs
Redcliffe Labs was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Redcliffe Labs is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
Aditya Kandoi is the current CEO of Redcliffe Labs. They have also founded this company.
Redcliffe Labs is a funded company, having raised a total of $116.42M across 4 funding rounds to date.
As of Aug 11, 2024, the latest employee count at Redcliffe Labs is 2,308.
Annual revenue of Redcliffe Labs is $41.86M as on Mar 31, 2023.
Redcliffe Labs was founded in 2018 in Noida, India, within the healthcare diagnostics sector. An online platform is operated to facilitate bookings for lab services, with samples collected at users doorsteps by phlebos. Reports generated from these tests are used to provide doctor consultations and personalized medicine recommendations. Operations focus on accessible home-based testing across India.
Redcliffe Labs's top competitors include Dr Lal PathLabs, Metropolis India and Orange health.
Redcliffe Labs offers Diagnostic Tests, Health Packages, and Sample Collection.
Redcliffe Labs has made 2 acquisitions, including Celara Diagnostics, and Medicentre.
Redcliffe Labs has 13 investors. Key investors include LetsVenture, LeapFrog Investments, Schroders, HealthQuad, and Nueva Capital.
The valuation of Redcliffe Labs is $229.38M as of Mar 2023.